Risk Stratification and Prognostic Value of Right Ventricular Dysfunction Screening Using Transthoracic Echocardiography in Acute Pulmonary Embolism
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Transthoracic Echocardiography.
- Who it may be relevant to
- Registry conditions: Pulmonary Embolism. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This observational study evaluates right ventricular dysfunction in patients with acute pulmonary embolism using transthoracic echocardiography and assesses its prognostic significance and risk stratification value.
Detailed description
This observational study evaluates right ventricular dysfunction in patients with acute pulmonary embolism using transthoracic echocardiography and assesses its prognostic significance and risk stratification value.
Interventions
- Other Transthoracic Echocardiography
Transthoracic echocardiography performed for assessment of right ventricular dysfunction in patients with acute pulmonary embolism.
Primary outcome measures
- Right ventricular dysfunction as a prognostic marker in acute pulmonary embolism [Time frame: From hospital admission until hospital discharge, with an average duration of 7 days.]
Secondary outcome measures (1)
- In-hospital adverse clinical outcomes [Time frame: From hospital admission until hospital discharge, with an average duration of 7 days.]
Eligibility criteria
Inclusion criteria
- Patients aged 18 years and older.
- Patients with a confirmed diagnosis of acute pulmonary embolism.
- Patients who underwent transthoracic echocardiographic assessment for right ventricular dysfunction.
Exclusion criteria
- Patients younger than 18 years.
- Patients with incomplete clinical data.
- Patients who did not undergo transthoracic echocardiography.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Egypt · 2 centers
- Sohag University hospital — Sohag
- Sohag University hospital — Sohag
Publications
- Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jimenez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ni Ainle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in co PMID 31504429
Identifiers
NCT: NCT07647497 · PE-RVD-2026-01...PE.RVD..2026.